ISIS 388626
ISIS 388626-CS1
Phase 1 small_molecule completed
Quick answer
ISIS 388626 for Type 2 Diabetes Mellitus is a Phase 1 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed